4-L-[131I]iodo-phenylalanine (131I-IPA)
131I-IPA-TLX-101-001
Phase 2 other completed
Quick answer
4-L-[131I]iodo-phenylalanine (131I-IPA) for Glioblastoma Multiforme is a Phase 2 program (other) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Telix Pharmaceuticals Ltd
- Indication
- Glioblastoma Multiforme
- Phase
- Phase 2
- Modality
- other
- Status
- completed